Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/14/13 → 11/14/16 |
Funding
- Janssen Biotech, Inc. (Prot #c11-092: NU MSK13U01)
- Memorial Sloan-Kettering Cancer Center (Prot #c11-092: NU MSK13U01)
Prot #c11-092: NU MSK13U01: A Phase 2, Randomized, 3-Arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, A GnRH Antagonist, and Degarelix Alone for Patients with Prostate Cancer with a Rising PSA Or A Rising PSA and Nodal Disease F
- Kuzel, Timothy Michael (PD/PI)
Project: Research project